Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
just because a form 4 was not filed, does not mean a cydy sale did not occur
when an insider executes a cydy transaction, he or she must file a Form 4.
With this form filing, the public is made aware of the insider’s various transactions in company securities, including the amount purchased
or sold and the price per share.
Form 4 must be filed within two business days following the transaction date.
Transactions in a company’s common stock as well as derivative securities, such as options, warrants, and convertible securities, are reported on the form. Each transaction is coded to indicate the nature of the transaction.
should go up 10% near term
much lower here, total train wreck
when he files his sec forms, that will be all the proof needed
the playbook for np and cydy is to roll-out leronbs every time a new medical issue arises to keep the game going...im sure the street has him and cydy figured out so the victim here will be small microcrap main street investor
in my opinion the stock will go lower, especially now that FYFE is involved in financing the company
if people researched the stock issued in the past by cydy and at the huge discount offered by mgt, then they would go invest in a different biotech stock
10 million s-8 shares to insiders this past month!
a $15m financing that cost the company over $2m in fees
is this the best a wonder drug can get?
cydy stock down since Charles Payne interview on Fox so perhaps other investors realized the drug is not new, even though CP and NP did not disclose all the facts
wonder if Charles Payne does this lack of due diligence on all his interviews
go watch the video again and see lack of disclosure by both parties
i would bet he sold his cydy shares and perhaps other insiders have sold their shares as well, it will be interesting to see who files their cydy required sec forms
KLUMP TAKES FREE CYDY STOCK AND THEN JUMPS SHIP
and they want to tout a billionaire had joined the board of directors
cydy ceo never talks about how old the drug is and that its IP is worthless without protection, hence no real financing, just FYFE
vaccines coming so the cv crisis IS solved soon without leronbs
thank for the link
are you the ceo?
hopefully you are right
high probability of R/S here,,,,99.99999%
how can you compare CYDY with Pfizer Inc.?
Pfizer is listed on NYSE
Revenue: 53.64 billion USD (2018)
Number of employees: 67,671 (2019)
revenues is something cydy know nothing about!
$300 real soon, this month probable
em lays off workers but his stock still trades, not much of a ceo
price is right
doesn't matter since cydy stock structure is no good, way too many shares issued for serious money, besides with Fyfe in the deal that is the final nail
always a good thing!
expect to go higher here
headed lower for sure
market cap could go higher here
CHART INDICATES HIGHER
TIME TO BUY
i believe your HIV is beyond 20 years and the way CYDY works it will be a long process with any new developments regardless of the emergency at hand
good to hear
could happen this month
$4 coming on this one
chart indicates further declines
expect sell-off to .50
during the Charles Payne interview the cydy ticker was showing $3.07 per share
wonder why it did not move higher with such great exposure?
i wonder who is selling stock into the market?
based on the IP age of leronlimab (expired), cydy has no protection from big pharma creating similar drug if proven to be effective
maybe this is why np does toxic financing as it is free money to him since the future is bleak for the company
more news on covid-19
“Seriously sick coronavirus patients in New York state’s largest hospital system are being given massive doses of vitamin C … Dr. Andrew G. Weber, a pulmonologist and critical-care specialist affiliated with two Northwell Health facilities on Long Island, said his intensive-care patients with the coronavirus immediately receive 1,500 milligrams of intravenous vitamin C.
Identical amounts of the powerful antioxidant are then re-administered three or four times a day, he said … The regimen is based on experimental treatments administered to people with the coronavirus in Shanghai, China …
‘The patients who received vitamin C did significantly better than those who did not get vitamin C,’ he said. ‘It helps a tremendous amount, but it is not highlighted because it’s not a sexy drug’ …
ask anyone and they will tell you leronlimab is not fda approved
it is only in fda trials
FOX MUST BE HURTING FOR CONTENT, BUT AT LEAST IT GIVES NP TIME TO PERFECT HIS INTERVIEW WITH ALL THE HELP SHAREHOLDERS ARE GIVING HIM
LERONLIMAB HAS TO BE PROVEN OR FDA APPROVED AND IT IS NOT
either np is in over his head or the leronlimab results really are not all that good for covid-19
many other patients recovered without leronlimab
take your pick!
ever again gets an opportunity to be interviewed is certainly the issue!